Peritoneal fluid from ovarian cancer patients stimulates MUC1 epithelial mucin expression in ovarian cancer cell lines

International Journal of Cancer

Volumn 76, Issue 3, 1998, Pages 393-398

  Munster, David J ^a   Quin, Rachel J ^a   Bansal, Amolak S ^a   Ward, Bruce G ^a   McGuckin, Michael A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MUCIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; OVARY CANCER; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIGENS, NEOPLASM; ASCITIC FLUID; BLOTTING, WESTERN; CA-15-3 ANTIGEN; CYTOKINES; FEMALE; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031779654     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980504)76:3<393::AID-IJC17>3.0.CO;2-C     Document Type: Article

References (26)

1. ABE, M. and KUFE, D.,Transcriptional regulation of DF3 gene expression in human MCF-7 breast carcinoma cel. Cell Physiol. 143, 226-231 (1990).
2. BANSAL, A.S., BRUCE, DEVINE, and ZIMMERM, V., Serum cytokines and tumour markers in patients with non-small cell carcinoma of the lung. Dis. Markers (1998) (In pres).
3. BEREK, J.S., WATSON, J.M. and MARTINEZ-MAZA., Role of interleukin-6 in ovarian canc, In: F. Sharp, W.P. Mason and W. Creasman (eds.), Ovarian cancer 2-Biology, diagnosis and management, 101-114, Chapman and Hall, London (1992).
4. BERTONCELLO, I., BRADLEY, T.R., WEBBER, L.M., HODGSON, G.S. and CAMPBELL, J., Human tumour cell lines established using clonal agar culture, Aust. J. exp. Biol. Med. Sci., 63, 241-248 (1985).
5. BURGER, R.A., GROSEN, A., IOLI, G.R., VANEDENE., M.E., PARK, M., BERMAN, M.L., DISAIA, P.J., GRANGER, G.A. and GATANAGA, T., Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcino. Interferon Cytokine Res. 15, 255-260 (1995).
6. CARSON, F., MORADI, M.M., LI, B.Y., OLSON, M.C., MOHANRAJ, D., ELG, S.A. and RAMAKRISHNAN, S. Characterization of cytokines produced by ovarian cancer cells. In: Sharp, W.P. Mason and W. Creasman (eds.), Ovarian cancer 2-Biology, diagnosis and management, 93-100, Chapman and Hall, London (1992).
7. CLARK, S., MCGUCKIN, M.A., HURST, T. and WARD, B.G., Effect of interferon-gamma and TNF-alpha on MUC1 mucin expression in ovarian carcinoma cell lines. Dis. Markers, 12, 43-50 (1994).
8. DEVINE, P.L., MCGUCKIN, M.A. and WARD, B.G., Circulating mucins as tumor markers in ovarian cancer (review) Anticancer Res., 12, 709-717 (1992).
9. DONG, Y., WALSH, M.D., CUMMINGS, M.C., WRIGHT, R.G., KHOO, S.K., PARSONS, P.G. and MCGUCKIN, M.A., Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J. Pathol. 183, 311-317 (1997).
10. FINN, O.J., JEROME, K.R., HENDERSON, R.A., PECHER, G., DOMENECH, N. and BARRATTBOYES, M., MUC-1 epithelial tumor mucin-based immunity and cancer vaccines [Review]. Immunol. Rev. 145, 61-89 (1995).
11. GIMMI, D., MORRISON, B.W., MAINPRICE, B.A., GRIBBEN, J.G., BoussioTIS, V.A., FREEMAN, G.J., PARK, S.Y.L., WATANABE, M., GONG, J.L., HAYES, D.F., KUFE, D.W. and NADLER, L.M., Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nature (Med.), 2, 1367-1370 (1996).
12. HEY, N.A., GRAHAM, R.A., SEIF, M.W. and APLIN, J.D., The polymorphic epithelial mucin MUC1 in human endometrium is regulated with maximal expression in the implantation phase. J. Endocrinol. Metab. 78, 337-342 (1994).
13. KOVARIK, A., PEAT, N., WILSON, D., GENDLER, S.J. and TAYLOR-PAPADIMITRIOU, J., Analysis of the tissue-specific promoter of the MUC1 gene. J. biol. Chem. 268, 9917-9926 (1993).
14. LANGDON, S.P., LAWRIE, S.S., HAY, F.G., HAWKES, M.M., MCDONALD, A., HAYWARD, I.P., SCHOL, D.J., HILGERS, J., LEONARD, R.C.F. and SMYTH, J.F., Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res., 48, 6166-6172 (1988).
15. MCGUCKIN, M.A., HURST, T.G. and WARD, B.G., Heterogeneity in production, secretion and glycosylation of MUC1 epithelial mucin by primary cultures of ovarian carcinoma. Int. J. Cancer, 63, 412-418 (1995a).
16. MCGUCKIN, M.A., WALSH, M.D., HOHN, B.C., WARD, B.C. and WRIGHT, R.G., Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum. Pathol., 26, 432-439 (1995b).
17. MORADI, M.M., CARSON, L.F., WEINBERG, B., HANEY, A.F., TWIGGS, L.B. and RAMAKRISHNAN, S., Serum and ascitic fluid levels of interleukin-1, interleukin-6. and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer, 72, 2433-2440 (1993).
18. PATTON, S., GENDLER, S.J. and SPICER, A.P., The epithelial mucin. MUC1, of milk, mammary gland and other tissues [review]. Biochim. biophys. Acta (Rev. Biomembranes), 1241, 407-423 (1995).
19. RADKE, J., SCHMIDT, D., BOHME, M., SCHMIDT, U., WEISE, W. and MORENZ, J., [Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma]. Geburtshilfe. Frauenheilkd., 56, 83-87 (1996).
20. Vos, H.L., VAN DER VALK, S.W., PRINSENBERG, T., MooI, W.J. and HILKENS, J., IL6-induction of the MUCl/episialin promoter in T47D cells. 4th International Workshop on Carcinoma-Associated Mucins, 30 (Abstract), (1996).
21. WARD, B.G., WALLACE, K., SHEPHERD, J.H. and BALKWILL, F.R., Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res., 47, 2662-2667 (1987).
22. WESSELING, J., VAN DER VALK, S.W., and HILKENS, J., A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membraneassociated mucin episialin/MUCl. Mol. Biol. Cell, 7, 565-577 (1996).
23. WOODS, L.K., MORGAN, R.T., QUINN, L.A., MOORE, G.E., SEMPLE, T.U. and STEDMAN, K.E., Comparison of four new cell lines from patients with adenocarcinoma of the ovary. Cancer Res., 39, 4449-4459 (1979).
24. XING, P.X., REYNOLDS, K., TJANDRA, J.J., TANG, X.L. and MCKENZIE, I.F., Synthetic peptides reactive with anti-human milk fat globule membrane monoclomal antibodies. Cancer Res., 50, 89-96 (1990).
25. ZHANG, K., BAECKSTROM, D., BREVINGE, H. and HANSSON, G.C., Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J. cell Biochem. 60, 538-549 (1996).
26. ZRIHAN-LICHT, S., BARUCH, A., ELROY-STEIN, O., KEYDAR, I. and WRESCHNER, D.H., Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins cytokine receptor-like molecules. FEBS Lett. 356, 130-136 (1994).